Plain-English translation of NCT05772104 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a herbal capsule called Shugan Jieyu Capsule can help treat generalized anxiety disorder (persistent, excessive worry that interferes with daily life). About 495 adults will take either the medication or a placebo (inactive pill) twice daily for up to 12 weeks, and researchers will measure how much their anxiety improves. The trial is being conducted across multiple medical centers.
Generalized anxiety disorder affects many people, but current treatments don't work for everyone or may cause side effects. This trial explores whether this traditional herbal treatment might offer a new option for people struggling with chronic anxiety.
You likely qualify if…
You likely don't qualify if…
You will take either the herbal capsule or a placebo pill four times daily (two capsules in the morning, two in the evening, at least 8 hours apart) for up to 12 weeks. You'll have multiple visits to the clinic where doctors will assess your anxiety symptoms using rating scales and check how well the treatment is working. The study uses a "double-blind" design, meaning neither you nor the researchers will know whether you're receiving the active medication or the placebo.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
China
Phase
Large-scale testing
Sponsor
Sichuan Jishengtang Pharmaceutical Co., Ltd.
Enrollment target
~495 participants
Started
April 2023
Primary completion
February 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ling Song
Beijing Anding Hospital Affiliated to Capital Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.